Carregant...
Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies
As many patients with underlying psychiatric disorders may be infected with COVID-19, and COVID-19-affected subjects may frequently experience a new onset of psychiatric manifestations, concomitant use of psychotropic medications and COVID-19 therapies is expected to be highly likely and raises conc...
Guardat en:
| Publicat a: | CNS Drugs |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053373/ https://ncbi.nlm.nih.gov/pubmed/33866523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-021-00811-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|